Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders

https://doi.org/10.1016/0090-1229(89)90114-1Get rights and content

Abstract

In this review new data are reported indicating that the thyroid microsomal-microvillar antigen can be identified with thyroid peroxidase (TPO). This concept derives from binding studies of monoclonal and polyclonal microsomal antibodies to TPO purified by affinity chromatography or obtained by recombinant DNA technology. Furthermore, immunofluorescence studies performed on cultured thyroid cells have shown the presence of a TPO-related antigen on the surface of the cells. The expression of the TPO antigen is modulated by TSH through the cAMP pathway. The functional activities of TSH receptor autoantibodies have also been characterized. From these studies the following conclusions can be drawn: (i) TSH receptor antibodies possess multiple biological activities, interfering or mimicking TSH actions; (ii) a good correlation is observed between stimulation of adenylate cyclase and of iodide uptake by Graves' IgG. In these IgC preparations, adenylate cyclase- and growth-stimulating activities cannot be separated; (iii) antibodies blocking the TSH-dependent AC are present in patients with autoimmune hypothyroidism; (iv) a mixture of stimulating and blocking antibodies may coexist in the same patient, whose clinical status may result from the sum of the biological activities of these antibodies. Finally, new data are reported on the identification and characterization of T cell clones infiltrating the thyroid tissue of subjects with thyroid autoimmune disorders. The majority of these clones were CD8+ cytolytic T cells with natural killer activity. These latter data may be of importance in the mechanisms of thyroid damage observed in Hashimoto's glands.

References (63)

  • A. Pinchera et al.
  • T. Hanafusa et al.

    Lancet

    (1983)
  • J.P. Banga et al.

    Mol. Immunol.

    (1985)
  • Y. Kajita et al.

    FEBS Lett.

    (1985)
  • B. Czarnocka et al.

    FEBS Lett.

    (1985)
  • G.F. Bottazzo et al.

    Lancet

    (1983)
  • J. Leclere et al.
  • R.D. Van Der Gaag et al.

    Lancet

    (1985)
  • J.B. Margolick et al.

    Sm. J. Med.

    (1984)
  • M. Bagnasco et al.

    Clin. Immunol. Immunopathol.

    (1988)
  • A.P. Weetman et al.

    Clin. Immunol. Immunopathol.

    (1986)
  • A.P. Weetman et al.

    Endocrinol. Rev.

    (1984)
  • R. Volpé

    Mol. Biol. Med.

    (1986)
  • S. Mariotti et al.

    Folia Allergol. Immunol. Clin.

    (1987)
  • G.F. Fenzi et al.
  • G.F. Fenzi et al.

    Clin. Exp. Immunol.

    (1982)
  • E.L. Khoury et al.

    Clin. Exp. Immunol.

    (1981)
  • E.L. Khoury et al.

    J. Exp. Med.

    (1984)
  • S. Mariotti et al.

    J. Clin. Endocrinol. Metab.

    (1979)
  • N. Hamada et al.

    J. Clin. Endocrinol. Metab.

    (1985)
  • B. Czarnocka et al.

    C. R. Acad. Sci. (Paris)

    (1985)
  • J.P. Banga et al.

    Clin. Exp. Immunol.

    (1986)
  • T. Kotani et al.

    J. Clin. Endocrinol. Metab.

    (1986)
  • L. Portmann et al.

    J. Clin. Endocrinol. Metab.

    (1985)
  • S. Mariotti et al.

    J. Clin. Endocrinol. Metab.

    (1987)
  • A. Pinchera et al.

    Acta Endocrinol. (Copenhagen) Suppl.

    (1987)
  • F. Libert et al.

    EMBO J.

    (1987)
  • P. Seto et al.

    J. Clin. Invest.

    (1987)
  • G.F. Bottazzo et al.

    Immunol. Rev.

    (1986)
  • M. Londei et al.

    Nature (London)

    (1984)
  • M. Londei et al.

    Science

    (1985)
  • Cited by (40)

    View all citing articles on Scopus

    Presented as part of a symposium entitled “Immunoregulation in Clinical Diseases,” May 26–27, 1988, Palazzo dei Congressi, Florence, Italy.

    View full text